Trial intelligence / Profile preview

Combination of Local and Oral Steroids for Esophageal Stricture Prevention After ESD

NCT03039608Completed

Sponsor
Zhongshan Hospital, Fudan University
Start
Feb 2017
Primary completion
Jul 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised trial of triamcinolone in Esophageal stricture (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: Stricture Rate at 12 weeks and Time When Stricture Occurs at 12 weeks. Started Feb 2017; status: completed.

02

Drugs

triamcinolone
03

Conditions

Esophageal stricture

Beyond the preview

Go deeper on NCT03039608.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03039608.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call